EUVIMED · CrossrefZeitschrift
American Journal of Psychiatry
ISSN 0002-953X · American Psychiatric Association Publishing
Neueste Artikel
Concerns About the Evidence Supporting Dextromethorphan-Bupropion in Depression
A Research Compendium Companion for DSM-6
Beyond Major Depressive Disorder: Why DSM-6 Should Recognize a Non-Melancholic Depressive Disorder
Gender Dysphoria and the Boundaries of Psychiatric Diagnosis in the Future DSM
Bringing a Developmental Perspective to the DSM : A Commentary on the Report From the Structure and Dimensions Subcommittee
The Future of DSM : Continued Response to Letters
Concerns About the Evidence Supporting Dextromethorphan-Bupropion in Depression: Response to Kennedy
Dose-Response Patterns and Pathways Linking Migration-Related Stigma and Mental Health
Targeted Use of Kudzu for Binge Drinking Among Adults With Alcohol Use Disorder: A Phase 2b Randomized Trial
Changing Patterns of Alcohol and Cannabis Acute Care Admissions by Age in the United States, 2016–2023
Mapping Individual Brain Deviations in ICD-11 Catatonia: Normative Modeling of Structural and Functional MRI Across Two Independent Cohorts
Association Between Age-Dependent DNA Methylation Changes at FKBP5 Enhancer Sites and Increased Cortical Gene Expression in Schizophrenia
Proteomic Signatures in Major Depressive Disorder and Depression Symptom Subtypes
Hippocampal Dentate Gyrus Plasticity and Its Association With Dimensional Clinical Improvement Across Four Depression Treatment Interventions
Prevalence and Correlates of Past-Year Psilocybin Use in the United States
The Pharmacotherapeutic Alliance: An Evidence-Based Intervention for Enhancing Psychiatric Outcomes
Rethinking Standard DLPFC Stimulation: The Role of Hemispheric Lateralization in Neuromodulation Treatment
Rethinking Standard DLPFC Stimulation: Response to Mundorf and Ocklenburg
Home-Based Neuromodulation for Depression: Rethinking Access and Oversight
Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications
Oldies but Goldies: The Targeted Antidepressant Effect of Electroconvulsive Therapy
From Stress Biology to Drug Target: What FKBP5 Adds to Psychiatric Drug Development
Toward Proteomic Biomarkers of Atypical Depression
Furthering the Understanding of Psilocybin Use and Molecules Relevant to Depression and Schizophrenia
Beyond the Sweet Spot: Hemispheric Asymmetry and Network Targeting in Depression DBS
Highlights From the Residents’ Journal: September 2026
Convergent Network Localization of Brain Stimulation Targets for Trait Anxiety
Connectomic Determinants of Subcallosal Cingulate Deep Brain Stimulation for Depression
Individualized Connectivity-Guided Versus Conventional Targeting of Accelerated Theta-Burst Stimulation in Depression: A Randomized, Double-Blind, Parallel-Design Trial
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial
Jahrgänge
2026 · 1372025 · 1752024 · 1922023 · 1522022 · 1572021 · 1752020 · 2202019 · 1922018 · 2672017 · 2572016 · 2712015 · 2762014 · 3122013 · 3242012 · 3192011 · 3492010 · 3912009 · 3962008 · 4502007 · 7982006 · 1.0292005 · 7322004 · 7522003 · 6262002 · 6892001 · 7922000 · 6421999 · 6831998 · 5591997 · 5101996 · 6991995 · 7111994 · 7481993 · 8331992 · 8791991 · 9411990 · 8461989 · 8931988 · 8431987 · 881
EUVIMED